28 USD
-0.83 (-2.88%)
27.51 USD
-0.49 (-1.75%)
ChartMill assigns a Buy % Consensus number of 82% to UPB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 62.22. This target is 122.21% above the current price.
UPB was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about UPB.
In the previous month the buy percentage consensus was at a similar level.
UPB was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-18 | Evercore ISI Group | Initiate | Outperform |
| 2025-10-14 | Truist Securities | Initiate | Buy |
| 2024-11-05 | TD Cowen | Initiate | Buy |
| 2024-11-05 | William Blair | Initiate | Outperform |
| 2024-11-05 | JP Morgan | Initiate | Overweight |
| 2024-11-05 | Piper Sandler | Initiate | Overweight |
UPSTREAM BIO INC / UPB FAQ
What is the price target for UPB stock?
9 analysts have analysed UPB and the average price target is 62.22 USD. This implies a price increase of 122.21% is expected in the next year compared to the current price of 28.
How do analysts rate UPSTREAM BIO INC (UPB)?
The consensus rating for UPSTREAM BIO INC (UPB) is 82.2222 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for UPB stock?
The number of analysts covering UPSTREAM BIO INC (UPB) is 9.